Production (Stage)
Comprehensive Healthcare Systems, Inc.
CHS.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.31% | 0.07% | -3.71% | -11.37% | -16.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.31% | 0.07% | -3.71% | -11.37% | -16.02% |
| Cost of Revenue | -46.84% | -47.74% | -25.30% | -12.23% | 16.93% |
| Gross Profit | 677.99% | 213.30% | 30.85% | -10.58% | -80.43% |
| SG&A Expenses | 479.74% | -59.11% | -68.30% | -60.39% | -109.98% |
| Depreciation & Amortization | -128.07% | 912.25% | -83.99% | 357.14% | 94.56% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.62% | -33.40% | -53.42% | -47.49% | -67.63% |
| Operating Income | -427.40% | 63.37% | 91.10% | 90.31% | 96.22% |
| Income Before Tax | -199.26% | 140.56% | 85.84% | 83.68% | 87.15% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -199.26% | 140.56% | 85.84% | 83.68% | 87.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -199.26% | 140.56% | 85.84% | 83.68% | 87.15% |
| EBIT | -427.40% | 63.37% | 91.10% | 90.31% | 96.22% |
| EBITDA | -439.40% | 62.60% | 89.99% | 90.61% | 96.38% |
| EPS Basic | -207.87% | 140.52% | 85.85% | 84.57% | 91.35% |
| Normalized Basic EPS | -121.43% | 71.87% | 85.84% | 84.56% | 91.83% |
| EPS Diluted | -207.87% | 140.52% | 85.85% | 84.57% | 91.35% |
| Normalized Diluted EPS | -121.43% | 71.87% | 85.84% | 84.56% | 91.83% |
| Average Basic Shares Outstanding | -2.86% | 0.00% | 0.00% | 5.79% | 48.69% |
| Average Diluted Shares Outstanding | -2.86% | 0.00% | 0.00% | 5.79% | 48.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |